SHANGHAI, China, Dec. 7 /Xinhua-PRNewswire/ -- WuXi PharmaTech Co. Ltd.,
China’s leading pharmaceutical R&D service company, announced today that
Merck & Co., Inc., of Whitehouse Station, NJ, USA, has agreed to extend and
expand an agreement through which WuXi provides a variety of chemistry-
related R&D services.
(Logo: http://www.prnasia.com/sa/200611271812.jpg )
The existing agreement between the two companies was signed in 2003. The
new expanded agreement, extended till 2010, offers additional opportunities
for collaboration, and substantially increases the number of full-time WuXi
scientists assisting Merck. A broader range of functional WuXi services
including synthesis, process research, and medicinal chemistry, will also be
utilized. Merck is one of the largest pharmaceutical companies to seek WuXi’
s services. Financial terms were not disclosed.
"This is a win-win opportunity for both sides,” says Dr. Ge Li, Chairman
and CEO of WuXi PharmaTech. “Our partnership with Merck helps us gain world
class experience, and at the same time helps Merck better deploy their R&D
resources. This agreement, the result of WuXi’s sustained high performance
on Merck projects, contributes greatly to our strategic target of becoming a
first-class fully integrated R&D service company,” continued Dr. Li.
About WuXi PharmaTech
WuXi PharmaTech Co., Ltd. is China’s leading pharmaceutical R&D and
manufacturing services provider. It provides its collaborative partners with
a broad and value-added service portfolio ranging from custom synthesis,
library production, lead generation and optimization, in vivo and in vitro
ADMET profiling, and bioanalytical services, to chemistry process development
and industrial manufacturing. For more information please visit
http://www.pharmatechs.com .
About Merck
Merck & Co., Inc. is a global research-driven pharmaceutical company
dedicated to putting patients first. Established in 1891, Merck currently
discovers, develops, manufactures and markets vaccines and medicines to
address unmet medical needs. The Company devotes extensive efforts to
increase access to medicines through far-reaching programs that not only
donate Merck medicines but help deliver them to the people who need them.
Merck also publishes unbiased health information as a not-for-profit
service. For more information, visit http://www.merck.com .
